The relationship between clinical and biochemical changes following neuroleptic treatment in schizophrenia
- 1 July 1990
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 3 (4) , 261-267
- https://doi.org/10.1016/0920-9964(90)90007-t
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Plasma Monoamine Metabolites in Psychotic DisordersArchives of General Psychiatry, 1988
- Cerebrospinal fluid homovanillic acid patterns during neuroleptic treatmentPsychiatry Research, 1981
- VI. The concurrent estimation of the major monoamine metabolites in human and non-human primate brain by HPLC with fluorescence and electrochemical detectionLife Sciences, 1981
- Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six monthsNature, 1979
- Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activityLife Sciences, 1978
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977
- Brain homovanillic acid: Regional changes over time with antipsychotic drugsEuropean Journal of Pharmacology, 1976
- Central Dopamine Turnover in Schizophrenic SyndromesArchives of General Psychiatry, 1974
- Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidolEuropean Journal of Pharmacology, 1973
- Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse BrainActa Pharmacologica et Toxicologica, 1963